Location History:
- Nantong, CN (2022)
- Jiangsu, CN (2024)
Company Filing History:
Years Active: 2022-2024
Title: Innovations of Hongzhi Xia in Biological Engineering
Introduction
Hongzhi Xia is a prominent inventor based in Nantong, China. He has made significant contributions to the field of genetic engineering and biological processes. With a total of 2 patents, his work focuses on enhancing the yield of valuable compounds through innovative methods.
Latest Patents
One of his latest patents is titled "Recombinant for increasing yield of menaquinone 7 and application thereof." This invention provides a recombinant method to increase the yield of menaquinone 7 (MK-7), which is crucial in various health applications. The patent describes the construction of 14 recombinant strains, BS1-BS14, which significantly enhance the MK-7 yield, reaching up to 33.5 mg/L, a remarkable increase compared to the original wild-type strain. Additionally, he has developed a "Method for preparing phosphatidylserine by ultrasonic-assisted enzymatic hydrolysis." This method utilizes ultrasonic technology to assist in the enzymatic hydrolysis of phosphatidylcholine and serine, achieving an enzymatic hydrolysis conversion rate of 98% or higher.
Career Highlights
Hongzhi Xia is associated with Nantong Licheng Biological Engineering Co. Ltd., where he applies his expertise in biological engineering. His innovative approaches have positioned him as a key figure in the development of high-yielding strains for various applications.
Collaborations
He collaborates with notable coworkers, including Jiangbo Li and Long Liu, contributing to advancements in their field.
Conclusion
Hongzhi Xia's innovative work in biological engineering showcases his commitment to enhancing the production of essential compounds through genetic engineering techniques. His contributions are paving the way for future advancements in the industry.